Malek Faham

Malek Faham is a seasoned expert in the fields of genetics and biotechnology, currently serving as Chief Scientist at Illumina Ventures since October 2017 and Chief Scientific Officer at AccuraGen since July 2015. Malek co-founded Sequenta Inc. and held the position of Chief Scientific Officer before its acquisition by Adaptive Biotechnologies, and also co-founded ParAllele BioScience, which was acquired by Affymetrix, where Malek served as VP of Oncology Technology Research. Other notable roles include advisory positions at Vineti and Convergent Genomics, as well as a research associate role at Stanford University's Genome Technology Center. Malek's academic foundation includes an MD and PhD in Medicine and Genetics from the University of California, San Francisco, following a BA in Biochemistry and Molecular Biology from the University of Maryland Baltimore County.